In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
In the latest session, Orthofix Medical Inc (NASDAQ: OFIX) closed at $14.89 down -0.60% from its previous closing price of $14.98. In other words, the price has decreased by -$0.60 from its previous closing price. On the day, 0.5 million shares were traded. OFIX stock price reached its highest trading level at $14.95 during the session, while it also had its lowest trading level at $14.61.
Ratios:
For a deeper understanding of Orthofix Medical Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.50 and its Current Ratio is at 2.67. In the meantime, Its Debt-to-Equity ratio is 0.45 whereas as Long-Term Debt/Eq ratio is at 0.44.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Canaccord Genuity on January 22, 2025, initiated with a Buy rating and assigned the stock a target price of $24.
On November 08, 2024, Stifel Upgraded its rating to Buy which previously was Hold and also upped its target price recommendation from $18 to $24. ROTH MKM Upgraded its Neutral to Buy on May 08, 2024, whereas the target price for the stock was revised from $15 to $20.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Aug 18 ’25 when Fisher Patrick sold 1,996 shares for $14.21 per share. The transaction valued at 28,363 led to the insider holds 30,116 shares of the business.
Engine Capital Management, LP bought 1,250 shares of OFIX for $13,881 on Jul 02 ’25. The 10% Owner now owns 3,546,057 shares after completing the transaction at $11.11 per share. On Jun 18 ’25, another insider, McPherron Aviva, who serves as the Pres, Global Ops & Qual of the company, sold 3,728 shares for $10.51 each. As a result, the insider received 39,181 and left with 46,322 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, OFIX now has a Market Capitalization of 588070144 and an Enterprise Value of 727201600. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.73 while its Price-to-Book (P/B) ratio in mrq is 1.28. Its current Enterprise Value per Revenue stands at 0.899 whereas that against EBITDA is 45.496.
Stock Price History:
The Beta on a monthly basis for OFIX is 0.86, which has changed by -0.103012025 over the last 52 weeks, in comparison to a change of 0.16222072 over the same period for the S&P500. Over the past 52 weeks, OFIX has reached a high of $20.73, while it has fallen to a 52-week low of $10.24. The 50-Day Moving Average of the stock is 21.67%, while the 200-Day Moving Average is calculated to be -0.42%.
Shares Statistics:
For the past three months, OFIX has traded an average of 434.21K shares per day and 497050 over the past ten days. A total of 39.48M shares are outstanding, with a floating share count of 38.70M. Insiders hold about 2.00% of the company’s shares, while institutions hold 91.73% stake in the company. Shares short for OFIX as of 1755216000 were 1982267 with a Short Ratio of 4.57, compared to 1752537600 on 2470409. Therefore, it implies a Short% of Shares Outstanding of 1982267 and a Short% of Float of 5.07.
Earnings Estimates
The firm’s stock currently is rated by 2.0 analysts. The consensus estimate for the next quarter is $0.26, with high estimates of $0.38 and low estimates of $0.15.
Analysts are recommending an EPS of between $0.54 and $0.36 for the fiscal current year, implying an average EPS of $0.45. EPS for the following year is $0.44, with 3.0 analysts recommending between $0.45 and $0.43.
Revenue Estimates
A total of 5 analysts believe the company’s revenue will be $199.93M this quarter.It ranges from a high estimate of $200.81M to a low estimate of $199M. As of the current estimate, Orthofix Medical Inc’s year-ago sales were $196.61MFor the next quarter, 5 analysts are estimating revenue of $220.66M. There is a high estimate of $226.6M for the next quarter, whereas the lowest estimate is $217.31M.
A total of 5 analysts have provided revenue estimates for OFIX’s current fiscal year. The highest revenue estimate was $816.2M, while the lowest revenue estimate was $811.63M, resulting in an average revenue estimate of $814.61M. In the same quarter a year ago, actual revenue was $799.49MBased on 5 analysts’ estimates, the company’s revenue will be $859.47M in the next fiscal year. The high estimate is $868.27M and the low estimate is $846.73M.
